These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 37356347)
1. Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP. Karlsson J; Wetterö J; Potempa LA; Fernandez-Botran R; O'Neill Y; Wirestam L; Mobarrez F; Sjöwall C J Autoimmun; 2023 Sep; 139():103073. PubMed ID: 37356347 [TBL] [Abstract][Full Text] [Related]
2. Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity. Karlsson J; Wetterö J; Weiner M; Rönnelid J; Fernandez-Botran R; Sjöwall C Arthritis Res Ther; 2022 Jun; 24(1):139. PubMed ID: 35690780 [TBL] [Abstract][Full Text] [Related]
3. The Role of Anti-mCRP Autoantibodies in Lupus Nephritis. Yuan M; Tan Y; Zhao MH Kidney Dis (Basel); 2023 Oct; 9(5):317-325. PubMed ID: 37901707 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions. Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis. Li QY; Li HY; Fu G; Yu F; Wu Y; Zhao MH J Am Soc Nephrol; 2017 Oct; 28(10):3044-3054. PubMed ID: 28566480 [TBL] [Abstract][Full Text] [Related]
6. Antibodies against monomeric C-reactive protein - a promising biomarker of lupus nephritis? Jakuszko K; Krajewska M; Kościelska-Kasprzak K; Myszka M; Sebastian A; Gniewek K; Wiland P; Klinger M Clin Biochem; 2017 Sep; 50(13-14):756-762. PubMed ID: 28300543 [TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles are associated with C-reactive protein in sepsis. Fendl B; Weiss R; Eichhorn T; Linsberger I; Afonyushkin T; Puhm F; Binder CJ; Fischer MB; Weber V Sci Rep; 2021 Mar; 11(1):6996. PubMed ID: 33772103 [TBL] [Abstract][Full Text] [Related]
8. Monomeric C-reactive protein is associated with severity and prognosis of decompensated hepatitis B cirrhosis. Gao N; Yuan P; Tang ZM; Lei JG; Yang ZR; Ahmed M; Yao ZY; Liang D; Wu Y; Li HY Front Immunol; 2024; 15():1407768. PubMed ID: 38895111 [TBL] [Abstract][Full Text] [Related]
10. Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type I interferon gene dysregulation. Svanberg C; Enocsson H; Govender M; Martinsson K; Potempa LA; Rajab IM; Fernandez-Botran R; Wetterö J; Larsson M; Sjöwall C J Autoimmun; 2023 Feb; 135():102998. PubMed ID: 36706536 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [TBL] [Abstract][Full Text] [Related]
12. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein. Yang XW; Tan Y; Yu F; Zhao MH Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784 [TBL] [Abstract][Full Text] [Related]
13. C-Reactive Protein and Cancer: Interpreting the Differential Bioactivities of Its Pentameric and Monomeric, Modified Isoforms. Potempa LA; Rajab IM; Olson ME; Hart PC Front Immunol; 2021; 12():744129. PubMed ID: 34552600 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up. Pesickova SS; Rysava R; Lenicek M; Vitek L; Potlukova E; Hruskova Z; Jancova E; Honsova E; Zavada J; Trendelenburg M; Tesar V Arthritis Res Ther; 2015 Dec; 17():371. PubMed ID: 26704903 [TBL] [Abstract][Full Text] [Related]
15. A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects. Olson ME; Hornick MG; Stefanski A; Albanna HR; Gjoni A; Hall GD; Hart PC; Rajab IM; Potempa LA Front Immunol; 2023; 14():1264383. PubMed ID: 37781355 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Sjöwall C; Zickert A; Skogh T; Wetterö J; Gunnarsson I Arthritis Res Ther; 2009; 11(6):R188. PubMed ID: 20003354 [TBL] [Abstract][Full Text] [Related]
17. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus. Haddon DJ; Diep VK; Price JV; Limb C; Utz PJ; Balboni I Arthritis Res Ther; 2015 Jun; 17(1):162. PubMed ID: 26081107 [TBL] [Abstract][Full Text] [Related]
18. Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Ahrens I; Domeij H; Eisenhardt SU; Topcic D; Albrecht M; Leitner E; Viitaniemi K; Jowett JB; Lappas M; Bode C; Haviv I; Peter K Basic Res Cardiol; 2011 Sep; 106(5):879-95. PubMed ID: 21562922 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against C-reactive protein (CRP) in sera of patients with systemic rheumatic diseases. Minatani M; Aotsuka S; Satoh T Mod Rheumatol; 2001 Jun; 11(2):127-31. PubMed ID: 24383688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]